Swiss National Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-124,400
Closed -$1.54M 2470
2024
Q4
$1.54M Hold
124,400
﹤0.01% 2001
2024
Q3
$1.42M Hold
124,400
﹤0.01% 2052
2024
Q2
$888K Hold
124,400
﹤0.01% 2221
2024
Q1
$833K Hold
124,400
﹤0.01% 2307
2023
Q4
$809K Sell
124,400
-13,500
-10% -$87K ﹤0.01% 2347
2023
Q3
$1.3M Buy
137,900
+1,700
+1% +$20.5K ﹤0.01% 2099
2023
Q2
$1.9M Buy
136,200
+2,000
+1% +$34.1K ﹤0.01% 1923
2023
Q1
$2.52M Sell
134,200
-15,900
-11% -$261K ﹤0.01% 1693
2022
Q4
$2.07M Buy
150,100
+3,700
+3% +$56.7K ﹤0.01% 1876
2022
Q3
$2.8M Buy
146,400
+1,400
+1% +$25.5K ﹤0.01% 1645
2022
Q2
$2.21M Hold
145,000
﹤0.01% 1838
2022
Q1
$2.95M Buy
145,000
+9,900
+7% +$202K ﹤0.01% 1795
2021
Q4
$3.94M Buy
135,100
+1,000
+0.7% +$28.6K ﹤0.01% 1624
2021
Q3
$2.89M Hold
134,100
﹤0.01% 1812
2021
Q2
$3.44M Buy
+134,100
New +$2.86M ﹤0.01% 1746

Other funds holding CDMO

Swiss National Bank's CDMO Position: Q1 2025 in Review

Swiss National Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 124,400 shares — an estimated $1.54M sold.

Swiss National Bank first reported a position in CDMO in Q2 2021 and held it in 15 quarters. The position peaked at $3.94M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Swiss National Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Swiss National Bank sold 124,400 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.54M.
  • Swiss National Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Swiss National Bank's Avid Bioservices, Inc. Common Stock position peaked at $3.94M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Swiss National Bank's 13F filing for Q1 2025, filed 12 May 2025.